MedicannX

Company Overview

Snapshot

Founded in July 2020 by Vitali Binyaminov, MedicannX operates with 1–10 employees. The company has raised a total of $18.95 million across one funding round from one investor. In July 2024, MedicannX secured significant funding to advance its medical cannabis cultivation and product development.

Business overview

MedicannX is a medical cannabis company focused on developing medical products using a unique aeroponic cultivation technology. The company's core technology involves an automated aeroponic cultivation system, four meters in height, where cannabis is grown and monitored in climate-controlled rooms, independent of external weather conditions. MedicannX primarily serves the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis, while also operating in Agriculture & Food Technologies.

Strategic signal

In July 2024, MedicannX announced a significant funding round, highlighting investor confidence in its unique aeroponic cultivation method for medical cannabis. This capital infusion is a strong signal of market validation for the company's technology and its potential to innovate within the medical cannabis and pharmaceutical sectors, suggesting an accelerated trajectory for product development and market expansion.

Company Intelligence Q&A

When was MedicannX founded?

MedicannX was founded in July 2020.

Who is the founder of MedicannX?

Vitali Binyaminov is the Founder & CEO of MedicannX.

What is MedicannX's primary sector?

MedicannX's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Cannabis.

What is MedicannX's core technology?

MedicannX utilizes an automated aeroponic cultivation method based on oxygen use for growing cannabis, with plants monitored in climate-controlled growing rooms.